ZERBAXA 1.5 g subst seche 1000 mg 10 pce
7680654720016
CH-65472
J01DI54
08.01.3.
Active substances:
1 / 2
Fiches Amavita / Sun Store / Coop Vitality
Details
- Product number
- 6547201
- CPT
- -
- Packaging group
- 10
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio sicca: ceftolozanum 1000 mg ut ceftolozani sulfas, tazobactamum 500 mg ut tazobactamum natricum, acidum citricum, natrii chloridum, argininum, pro vitro corresp. natrium 230 mg.
Articles (1)
Zerbaxa 1.5 g, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
10
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
ceftolozanum
|
1000.0 MG | Substance | Wirkstoff (Principe actif) |
|
ceftolozani sulfas
|
- | Substance | WIZUS |
|
tazobactamum
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
tazobactamum natricum
|
- | Substance | WIZUS |
|
acidum citricum
|
- | Substance | HNIDK |
|
natrii chloridum
|
- | Substance | HNIDK |
|
argininum
|
- | Substance | HNIDK |
|
natrium
|
230.0 MG | Substance | HBESI |
Authorization holder
MSD Merck Sharp & Dohme AG
6005 Luzern
Authorization information
- Swissmedic authorization number
- 65472
- Drug name
- Zerbaxa, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- PULPA
- ATC Code
- J01DI54
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 03/03/2016
- Authorization expiration date
- 31/12/9999
- IT number
- 08.01.3.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ZERBAXA 1.5 g subst seche 1000 mg 10 pce
- Description (DE)
- ZERBAXA 1.5 g Trockensub 1000 mg 10 Stk
- Market launch
- 03/03/2016
- Narcotic (BTM)
- No